Deal Flow
Letter · prints on one page
Transaction tear sheetData as of Nov 7, 2026
M&A · Healthcare · Services-Misc Health & Allied Services, NEC

Patient Square Capital to acquire SOC Telemed, Inc.

Announced Feb 3, 2022 · Closed Apr 6, 2022

Deal value$303MEV $327M
Premium—To unaffected price
EV / Adj. EBITDA—4.0x EV / Revenue
ConsiderationAll cash$3.00 per share

Transaction

Acquirer
Patient Square Capital
Target
SOC Telemed, Inc. (TLMD)
Buyer type
Private equity
Offer price per share
$3.00
Enterprise value
$327M
Status
Closed Apr 6, 2022

Deal protections

Break fee (target pays)
$11.5M · 3.8%
Reverse fee (buyer pays)
—
Go-shop
Go-shop
Financing
No financing condition

Advisors

To the acquirer
Not disclosed
To the target
William Blair

Sector context · Healthcare

Comparable deals
35 in the prior 24 months
Premium
Sector median 45.5%
EV / Adj. EBITDA
Sector median 20.4x
Break fee
3.8% vs. 3.4% sector median

Timeline

  1. AnnouncedFeb 3, 2022
  2. Proxy filedFeb 23, 2022
  3. Definitive proxyMar 7, 2022
  4. Shareholder voteApr 4, 2022
  5. ClosedApr 6, 2022

Valuation · fairness opinions

Discounted cash flow$1.51$3.48
Offer $3.00

Implied value per SOC Telemed, Inc. share by analysis, from William Blair · DCF discount rate 14%–16%.

Sources
  • 8-K (EX-99.1) · Feb 3, 2022
  • DEFA14A (EX-99.1) · Feb 3, 2022
  • 8-K · Feb 4, 2022
  • 8-K (EX-99.1) · Apr 6, 2022

Adj. EBITDA is operating income + D&A + impairment, restructuring, deal costs and stock compensation, less any large gain on a sale, last twelve months, from the target's filings. Calculated by Castle, so it can differ from a bank's adjusted figure.

Prepared with Castle from public SEC EDGAR filings. Figures are extracted automatically; verify against the source documents. Not investment advice.